Table 2.
Analysis of combined rT7SS (AM + PM)—ITT population
| Variable time point | Treatment | N | Mean (SD) | LSM | Source | p value | Treatment difference [95% (CI)] |
|---|---|---|---|---|---|---|---|
| Baseline | MP-AzeFlu | 300 | 25.40 (6.96) | 25.08 | Treatment | 0.6703 | |
| Aze | 298 | 24.89 (7.07) | 24.61 | ||||
| Flu | 299 | 24.97 (7.33) | 24.72 | ||||
| Day 2 to day 7 change from baseline (AM + PM) | MP-AzeFlu | 300 | − 8.33 (7.64) | − 8.11 | |||
| Aze | 298 | − 5.20 (7.58) | − 5.95 | MP-AzeFlu vs. Aze | < 0.0001 | − 1.73 (− 3.05, − 1.28) | |
| Flu | 299 | − 6.55(8.01) | − 6.24 | MP-AzeFlu vs. Flu | < 0.0001 | − 1.17 (− 2.76, − 0.99) | |
| Day 2 to day 14 change from baseline (AM + PM) | MP-AzeFlu | 300 | − 11.00 (8.71) | − 10.69 | |||
| Aze | 298 | − 7.17 (8.87) | -8.29 | MP-AzeFlu vs. Aze | < 0.0001 | − 1.96 (− 3.26, − 1.54) | |
| Flu | 299 | − 9.77 (9.31) | − 9.10 | MP-AzeFlu vs. Flu | 0.0003 | − 0.98 (− 2.44, − 0.73) |